Phase I/II study of R340 (Capecitabine), L-OHP (Oxaliplatin) and R435 (Bevacizumab) in advanced and/or metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/99396
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: investigational material(s)
Generic name etc : Capecitabine|Oxaliplatin|Bevacizumab
INN of investigational material :
Therapeutic category code : 42- Antineoplastic agents
Dosage and Administration for Investigational material : Capecitabine: oral administration Oxaliplatin and Bevacizumab: injection
Primary outcome(s): Response Rate, Safety
Study Design: Open, Single Arm study
创建时间：
2006-06-15
